Help Us Protect Access to Sexual and Reproductive Health Care Today!
May 16
Some people prefer to take hormonal birth control without estrogen. This fact sheet highlights the progestin-only options that are available. Spanish: Updated 2025 Reading Grade Level (Flesch-Kincaid Grade Level): 6.2 Sources: CDC – Injectables – US SPR – Reproductive Health. Centers for Disease Control and Prevention. https://www.cdc.gov/reproductivehealth/contraception/mmwr/spr/injectables.html. Published May 20, 2021. Accessed…
Apr 17
This factsheet compares birth control options that contain estrogen and progestin: the pill, patch, and ring.
Apr 16
This clinical guide explains how health care providers can Quick Start contraception.
Feb 04
A tool for health care providers who want to check a patient’s medical eligibility for various forms of contraception as they relate to absolute and relative contraindications.
Jan 15
This sheet answers common patient questions about continuous use of birth control (especially the pill, patch, and ring), skipping periods and explains how to do so safely.
Sep 19
Birth control pills, emergency contraceptive pills, and abortion pills are three different types of medications that are used in reproductive health care. One main difference between them is that birth control pills and emergency contraceptive pills prevent pregnancy, while abortion pills end a pregnancy. Learn more about how these medications are different from one another…
Aug 22
Explains the basics of how to use the progestin-only pill.
Apr 16
This poster compares birth control choices based on efficacy, cost, side effects, and other patient-focused factors.
Nov 04
This presentation is a teaching tool that was created for a clinical audience to demonstrate medical contraindications to contraceptive use using the CDC Medical Eligibility Criteria for Initiating Contraception.
Nov 03
This presentation is a teaching tool was created for a clinical audience to demonstrate how to use WHO/CDC categories for eligibility, how to counsel patients about contraceptive efficacy for successful prevention of unintended pregnancy and to address systems practices which can affect contraceptive initiation and continuation rates.